"
Team:Carnegie Mellon/Bio-Submitted
From 2012.igem.org
(Difference between revisions)
| Line 9: | Line 9: | ||
<ul> | <ul> | ||
<li> | <li> | ||
| - | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Hom- | + | <a href="https://2012.igem.org/Team:Carnegie_Mellon">Overview</a> |
| + | </li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Hom-Introduction">Introduction</a> | ||
</li> | </li> | ||
<li> | <li> | ||
| Line 26: | Line 29: | ||
<a href="https://2012.igem.org/Team:Carnegie_Mellon/Bio-Overview">Overview</a> | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Bio-Overview">Overview</a> | ||
</li> | </li> | ||
| - | <li class="current"> | + | <li class="current" > |
<a href="https://2012.igem.org/Team:Carnegie_Mellon/Bio-Submitted">Submitted Parts</a> | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Bio-Submitted">Submitted Parts</a> | ||
</li> | </li> | ||
| Line 36: | Line 39: | ||
<li style ='width: 193px'> | <li style ='width: 193px'> | ||
| - | <a href="https://2012.igem.org/Team:Carnegie_Mellon/ | + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Overview">Methods and Results</a> |
<ul> | <ul> | ||
<li class = 'offset' style ='width: 386px'> <a href="#"></a></li> | <li class = 'offset' style ='width: 386px'> <a href="#"></a></li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Overview">Overview</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Results">Results</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Protocols">Protocols</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Challenges">Challenges</a> | ||
| + | </li> | ||
| + | <li> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Met-Notebook">Notebook</a> | ||
| + | </ul> | ||
| + | </li> | ||
| + | |||
| + | <li style ='width: 193px'> | ||
| + | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Mod-Overview">Modeling</a> | ||
| + | <ul> | ||
| + | <li class = 'offset' style ='width: 579px'> <a href="#"></a></li> | ||
<li> | <li> | ||
<a href="https://2012.igem.org/Team:Carnegie_Mellon/Mod-Overview">Overview</a> | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Mod-Overview">Overview</a> | ||
| Line 54: | Line 78: | ||
<a href="https://2012.igem.org/Team:Carnegie_Mellon/Hum-Overview">Human Practices</a> | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Hum-Overview">Human Practices</a> | ||
<ul> | <ul> | ||
| - | <li class = 'offset' style ='width: | + | <li class = 'offset' style ='width: 687px'> <a href="#"></a></li> |
<li> | <li> | ||
<a href="https://2012.igem.org/Team:Carnegie_Mellon/Hum-Overview">Overview</a> | <a href="https://2012.igem.org/Team:Carnegie_Mellon/Hum-Overview">Overview</a> | ||
| Line 74: | Line 98: | ||
</ul> | </ul> | ||
</li> | </li> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</ul> | </ul> | ||
<br /><br /><br /> | <br /><br /><br /> | ||
| + | |||
<!--Main Contents --> | <!--Main Contents --> | ||
| Line 98: | Line 106: | ||
<!--Table of Contents | <!--Table of Contents | ||
| + | <!-- Remove for testing | ||
<div id="toc-holder" class="toc-holder"> | <div id="toc-holder" class="toc-holder"> | ||
<a href="#" class="toc-link" id="toc-link"><span>▼</span> Table of Contents</a> | <a href="#" class="toc-link" id="toc-link"><span>▼</span> Table of Contents</a> | ||
| Line 110: | Line 119: | ||
</ul> | </ul> | ||
| - | </div><!-- .toc-holder --> | + | </div> |
| + | --> | ||
| + | <!-- .toc-holder --> | ||
<div class = "main_content"> | <div class = "main_content"> | ||
Revision as of 19:53, 29 September 2012
Submitted Parts
BBa_K613007: TAATACGACTCACTATAGGGAGAGGAATTGTGAGCGGATAACAA
Mutant I: TAATGCGACTCACTATAGGACAATTGTGGGCGGACAACAATTCCAA
Mutant II: TAATACGACTCACTACAGGGCGGAATTGTGAGCGGATAACAATTCCAA
Mutant III: CAATCCGACTCACTAAAGAGAGAATTGTGAGCGGATAACAATTCCAA
Hypothesis:
Expected promoter strength of different mutants:Mutant I: <100%
Mutant II: ~100%
Mutant III: ~50%
Expected LacI leaky expression of different mutants:
Mutant I: More than average
Mutant II: Average
Mutant III: Average
